150 related articles for article (PubMed ID: 1742082)
1. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells.
Törnevik Y; Jacobsson B; Britton S; Eriksson S
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):751-9. PubMed ID: 1742082
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells.
Qian M; Chandrasena G; Ho RJ; Unadkat JD
Antimicrob Agents Chemother; 1994 Oct; 38(10):2398-403. PubMed ID: 7840577
[TBL] [Abstract][Full Text] [Related]
5. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
[TBL] [Abstract][Full Text] [Related]
6. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
Zhu Z; Schinazi RF; Chu CK; Williams GJ; Colby CB; Sommadossi JP
Mol Pharmacol; 1990 Dec; 38(6):929-38. PubMed ID: 2250666
[TBL] [Abstract][Full Text] [Related]
7. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
Fridland A; Connelly MC; Ashmun R
Mol Pharmacol; 1990 May; 37(5):665-70. PubMed ID: 2338944
[TBL] [Abstract][Full Text] [Related]
8. A method for the quantification of intracellular zidovudine nucleotides.
Kuster H; Vogt M; Joos B; Nadai V; Lüthy R
J Infect Dis; 1991 Oct; 164(4):773-6. PubMed ID: 1894938
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
Kinai E; Gatanaga H; Kikuchi Y; Oka S; Kato S
J Mass Spectrom; 2015 Jun; 50(6):783-91. PubMed ID: 26169132
[TBL] [Abstract][Full Text] [Related]
10. A sensitive nonisotopic method for the determination of intracellular azidothymidine 5'-mono-, 5'-di-, and 5'-triphosphate.
Toyoshima T; Kimura S; Muramatsu S; Takahagi H; Shimada K
Anal Biochem; 1991 Aug; 196(2):302-7. PubMed ID: 1776679
[TBL] [Abstract][Full Text] [Related]
11. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
Avramis VI; Kwock R; Solorzano MM; Gomperts E
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
[TBL] [Abstract][Full Text] [Related]
12. 3'-Azido-3'-deoxythymidine-(5')-tetraphospho-(5')-adenosine, the product of ATP-mediated excision of chain-terminating AZTMP, is a potent chain-terminating substrate for HIV-1 reverse transcriptase.
Dharmasena S; Pongracz Z; Arnold E; Sarafianos SG; Parniak MA
Biochemistry; 2007 Jan; 46(3):828-36. PubMed ID: 17223704
[TBL] [Abstract][Full Text] [Related]
13. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
[TBL] [Abstract][Full Text] [Related]
14. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP.
Ostermann N; Lavie A; Padiyar S; Brundiers R; Veit T; Reinstein J; Goody RS; Konrad M; Schlichting I
J Mol Biol; 2000 Nov; 304(1):43-53. PubMed ID: 11071809
[TBL] [Abstract][Full Text] [Related]
15. Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
Compain S; Durand-Gasselin L; Grassi J; Benech H
J Mass Spectrom; 2007 Mar; 42(3):389-404. PubMed ID: 17238240
[TBL] [Abstract][Full Text] [Related]
16. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
Darnowski JW; Goulette FA
Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.
McKee EE; Bentley AT; Hatch M; Gingerich J; Susan-Resiga D
Cardiovasc Toxicol; 2004; 4(2):155-67. PubMed ID: 15371631
[TBL] [Abstract][Full Text] [Related]
18. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
Kerr SG; Anderson KS
Biochemistry; 1997 Nov; 36(46):14064-70. PubMed ID: 9369478
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of intracellular levels of 5'-monophosphate-AZT using an enzyme immunoassay.
Goujon L; Brossette T; Dereudre-Bosquet N; Creminon C; Clayette P; Dormont D; Mioskowski C; Lebeau L; Grassi J
J Immunol Methods; 1998 Sep; 218(1-2):19-30. PubMed ID: 9819120
[TBL] [Abstract][Full Text] [Related]
20. Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients?
Johnson S
Med Hypotheses; 2001 Mar; 56(3):409-10. PubMed ID: 11359372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
